Journal Mobile Options
Table of Contents
Vol. 10, No. 6, 1999
Issue release date: November–December 1999
Dement Geriatr Cogn Disord 1999;10:511–517
(DOI:10.1159/000017198)

Behavioral and Psychological Symptoms in Alzheimer’s Disease

Relation between Apathy and Regional Cerebral Perfusion

Benoit M. · Dygai I. · Migneco O. · Robert P.H. · Bertogliati C. · Darcourt J. · Benoliel J. · Aubin-Brunet V. · Pringuey D.
aMemory Center, Department of Psychiatry, and bDepartment of Biophysics and Nuclear Medicine, University of Nice, Sophia Antipolis, France

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Fundamental and therapeutic research in Alzheimer’s disease (AD) focused for a long time exclusively on cognitive aspects. However, AD also frequently involves complex disorders of affect and behavior, which are currently grouped under the heading ‘behavioral and psychological signs and symptoms of dementia’ (BPSSD). Several rating tools have been developed over the years on the basis of a variety of source data. Some are derived from psychiatric practise or have specifically been developed for dementia, such as the Neuropsychiatric Inventory (NPI). In this study we prospectively used the NPI to examine BPSSD. Sixty-three French patients (mean age 74.7 years, SD 7.9) with a Mini-Mental State Examination (MMSE) score higher than 10 were examined. BPPSD were detected by NPI in 95.2% of the patients. Anxiety was the most common abnormality (65.1%), followed by apathy and dysphoria (58.7%). The highest frequency × severity NPI score was observed for apathy. In order to identify the relationship between regional cerebral perfusion and apathy, 20 of these AD patients underwent a technetium-99m-bicisate SPECT protocol within the same week as the NPI evaluation. The mean age of this population was 74.4 years (SD 5.3) and the mean MMSE score was 21 (SD 4.1). The apathy NPI score was correlated with right cingulate deficit whereas the highest correlation for the MMSE was with the left temporoparietal area. This stresses the interest to focus on SPECT imaging of AD patients not only in the posterior areas.

Copyright©1999S.KargerAG,Basel



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Teri L, Hughes JP, Larson EB: Cognitive deterioration in Alzheimer’s disease: Behavioral and health factors. J Gerontol 1990;45:58–63.
  2. Mortimer JA, Ebbitt B: Predictors of cognitive and functional progression in patients with probable Alzheimer’s disease. Neurology 1992;42:1689–1696.
  3. Finkel SI, Costa e Silva J, Cohen G, Miller S, Sartorius N: Behavioral and psychological signs and symptoms of dementia: A consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr 1996;8:497–500.

    External Resources

  4. Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E: Behavioral symptoms in Alzheimer’s disease: Phenomenology and treatment. J Clin Psychiatry 1987;48:9–15.
  5. Cohen-Mansfield J: Agitation in the elderly; in Bilig N, Rabins P (eds): Advances in Psychosomatic Medicine: Geriatric Psychiatry. Basel, Karger, 1989, pp 101–113.
  6. Cummings JL, Mega MS, Gray K, Rosemberg-Thompson S, Gornbein T: The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308–2314.
  7. Mega M, Cummings JL, Fiorello T: The spectrum of behavioral changes in Alzheimer’s disease. Neurology 1996;46:130–135.
  8. Hirono N, Mori E, Ikejiri Y, Imamura T, Shimomura T, Hashimoto S, Yamashita H, Ikeda M: Japanese version of the Neuropsychiatric Inventory: A scoring system for neuropsychiatric disturbance in dementia patients. No To Shinkei 1997;49:266–271.
  9. Cummings JL, Diaz C, Levy M: Behavioral syndromes in neurodegenerative diseases: Frequency and significance. Semin Neuropsychiatry 1996;1:241–247.
  10. Marin RS: Differential diagnosis and classification of apathy. Am J Psychiatry 1990;147:22–30.
  11. Stuss DT, Benson DF: The Frontal Lobes. New York, Raven Press, 1986.
  12. Marin RS, Firinciogullari S, Biedrzycki RC: Group differences in the relationship between apathy and depression. J Nerv Ment Dis 1994;182:235–239.
  13. Andreasen NC: Negative symptoms in schizophrenia – Definition and reliability. Arch Gen Psychiatry 1982;39:784–788.
  14. Levy ML, Cummings JL, Fairbanks LA, Masterman D, Miller BL, Craig AH, Paulsen JS, Litvan I: Apathy is not depression. J Neuropsychiatry 1998;10:314–319.
  15. Marin RS: Apathy: A neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 1991;3:243–254.
  16. Bonte F, Ross E, Chehabi H: SPECT study of regional cerebral blood flow in Alzheimer’s disease. J Comput Assist Tomogr 1986;10:579–583.

    External Resources

  17. Robert PH, Migneco O, Darcourt J, Ricq O, Aubin V, Bonhomme P, Pringuey D, Lapalus F, Darcourt G: Correlation between 99mTc-HMPAO brain uptake and severity of dementia in Alzheimer’s disease: Assessment using an automatized technique. Dementia 1992;3:15–20.
  18. Sultzer DL, Mahler ME, Mandelkern MA, Cummings JL, Van Gorp WG: The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 1995;7:476–484.
  19. Pull CB: Classification internationale des troubles mentaux et des troubles du comportement. CIM-10/ICD-10. Genève, Masson, 1992.
  20. McKhann G, Drachman D, Folstein M, Katzman R, Pice D, Stadian EM: Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer’s disease. Neurology 1984;34:189–198.
  21. Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental test’: A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;12:189–198.
  22. Cummings JL: The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients. Neurology 1997;48(suppl 6):s10–s16.
  23. Robert PH, Médecin I, Vincent S, Staccini P, Cattelin F, Goni S: L’inventaire neuropsychiatrique: validation de la version française d’un instrument destiné à évaluer les troubles du comportement chez les sujets déments. Année Gérontol Mal Alzheimer 1998;5:63–86.
  24. Talairach J, Tournoux P: Co-Planar Stereotaxic Atlas of the Human Brain. Stuttgart, Thieme, 1988.
  25. Molchan SE, Little JT, Cantillon M, Sunderland T: Psychosis; in Lawlor BA (ed): Behavioral Complications of Alzheimer’s Disease. Washington, American Psychiatric Press, 1995, pp 55–76.
  26. Eastwood R, Reisberg B: Mood and behaviour; in Gauthier S (ed): Clinical Diagnosis and Management of Alzheimer’s Disease. London, Dunitz, 1996, pp 175–187.
  27. Rubin EH, Morris JC, Storandt M, Berg L: Behavioral changes in patients with mild senile dementia of the Alzheimer’s type. Psychiatry Res 1987;21:55–62.
  28. Greenwald BS: Depression in Alzheimer’s disease and related dementia; in Lawlor BA (ed): Behavioral Complications of Alzheimer’s Disease. Washington, American Psychiatric Press, 1995, pp 19–53.
  29. Weiner MF, Svetlik D, Risser RC: What depressive symptoms are reported in Alzheimer’s patients? Int J Geriatric Psychiatry 1997;12:648–652.
  30. Gilley DW: Behavioral and affective disturbances in Alzheimer’s disease; in Parks R, Zec RF, Wilson RS (eds): Neuropsychology of Alzheimer’s Disease and Other Dementias. New York, Oxford University Press, 1993, pp 112–137.
  31. Marin RS, Fogel BS, Hawkins J, Duffy J, Krupp B: Apathy: A treatable syndrome. J Neuropsychiatry Clin Neurosci 1995;7:23–30.
  32. Hirono N, Mori E, Ishii K, Ikejiri Y, Imamura T, Shimomura T, Hashimoto S, Yamashita H, Sasaki M: Frontal lobe hypometabolism and depression in Alzheimer’s disease. Neurology 1998;50:380–383.
  33. Craig AH, Cummings JL, Fairbanks L, Itti L, Miller BL, Li L, Mena I: Cerebral blood flow correlates of apathy in Alzheimer disease. Arch Neurol 1996;53:1116–1120.
  34. Devinsky O, Morrell M, Vogt B: Contributions of anterior cingulate cortex to behaviour. Brain 1995;118:279–306.

    External Resources

  35. Mega MS, Cummings JL: The cingulate and cingulate syndromes; in Trimble MR, Cummings JL (eds): Contemporary Behavioral Neurology. Boston, Butterworth-Heinemann, 1997, pp 189–214.
  36. Kaufer D, Cummings JL, Christine D: Effect of tacrine on behavioral symptoms in Alzheimer’s disease: An open-label study. J Geriatr Psychiatry Neurol 1996;9:1–6.
  37. Kaufer D: Beyond the cholinergic hypothesis: The effect of metrifonate and other cholinesterase inhibitors on neuropsychiatric symptoms in Alzheimer’s disease. Dementia Geriatr Cogn Disord 1998;9(suppl 2):8–14.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50